Workshop on Choosing hepatitis B drugs for patients with HBV

On July 4, 2009, Khuong Duy DP Company cooperated with STADA-Vietnam manufacturer to hold a roundtable discussion on the treatment of chronic HBV infection at the hall of Khuong Duy Company. The conference attracted more than 50 guests who are doctors and pharmacists working in the inner city. HCM with the chairmanship of BS. CCII Nguyen Huu Chi.

Hepatitis B is becoming more and more common and concentrated in Southeast Asia. It can be said that, with constant efforts in finding quality products, Khuong Duy Pharma has made a significant contribution to the cause of public health service, creating autonomy in specialty pharmaceuticals for the medical industry. Vietnam economy.

Leave a Comment